Tag : COPD

In the NOVELTY study, higher baseline blood eosinophils (EOS) significantly predicted increased exacerbation risks in asthma and chronic obstructive pulmonary disease (COPD). Conversely, FeNO showed highly heterogeneous associations, paradoxically linking to a lower overall risk in COPD but increased odds of oral corticosteroid-treated exacerbations in asthma and asthma + COPD.

Despite advancements in supportive therapies for chronic obstructive pulmonary disease (COPD), many patients continue to suffer from persistent breathlessness, often due to progressive lung hyperinflation. Management traditionally focused on symptom control, with long-term oxygen therapy (LTOT) introduced in advanced or palliative stages.